BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
BillionToOne, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$101.03+2.91 (+2.97%)
Close on Oct 19, 2026
- Market cap
- $5.50B
- P/E (TTM)
- 721.6
- Dividend yield
- –
BillionToOne statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | BillionToOne | Industry median |
|---|---|---|
| Market Cap | $4.77B | $1.14B |
| Enterprise Value | $4.22B | $1.35B |
| PS Ratio | 12.00 | 1.63 |
| PB Ratio | 8.88 | 3.03 |
| P/TBV Ratio | 8.88 | 4.99 |
| P/FCF Ratio | 143.71 | 20.54 |
| P/OCF Ratio | 105.11 | 15.44 |
Enterprise value
| Measure | BillionToOne | Industry median |
|---|---|---|
| EV / Sales | 10.62 | 1.78 |
| EV / EBITDA | 83.99 | 14.40 |
| EV / EBIT | 97.42 | 19.04 |
| EV / FCF | 127.17 | 23.16 |
Income (trailing twelve months)
| Measure | BillionToOne | Industry median |
|---|---|---|
| Revenue | $397.41M | $561.90M |
| Gross Profit | $283.22M | $173.32M |
| Operating Income | $43.30M | -$1.81M |
| Pretax Income | $37.91M | -$572.42K |
| Net Income | $37.71M | -$1.16M |
| EBITDA | $50.23M | -$20.72K |
Margins
| Measure | BillionToOne | Industry median |
|---|---|---|
| Gross Margin | 71.3% | 33.1% |
| Operating Margin | 10.9% | -4.45% |
| Pretax Margin | 9.54% | 1.54% |
| Profit Margin | 9.49% | -2.91% |
| EBITDA Margin | 12.6% | 2.41% |
| FCF Margin | 8.35% | 3.13% |
Returns
| Measure | BillionToOne | Industry median |
|---|---|---|
| Return on Equity (ROE) | 26.3% | 1.84% |
| Return on Assets (ROA) | 5.17% | -3.06% |
| Return on Capital Employed (ROCE) | 6.42% | -0.57% |
Growth
| Measure | BillionToOne | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 90.1% | 6.92% |
Balance sheet
| Measure | BillionToOne | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $548.63M | $48.71M |
| Net Cash (Debt) | $548.63M | $205.49K |
| Net Cash Per Share | $11.63 | $0.01 |
| Equity (Book Value) | $536.81M | $235.16M |
| Book Value Per Share | $11.38 | $3.48 |
| Tangible Book Value | $536.81M | $703.69K |
| Working Capital | $595.65M | $30.48M |
Financial position
| Measure | BillionToOne | Industry median |
|---|---|---|
| Current Ratio | 11.69 | 1.40 |
| Quick Ratio | 11.19 | 1.02 |
| Interest Coverage | 1056.15 | -0.63 |
Cash flow (trailing twelve months)
| Measure | BillionToOne | Industry median |
|---|---|---|
| Operating Cash Flow | $45.35M | $3.10M |
| Capital Expenditures | -$12.18M | -$18.62M |
| Free Cash Flow | $33.17M | $23.73M |
| FCF Per Share | $0.70 | $0.37 |
Efficiency
| Measure | BillionToOne | Industry median |
|---|---|---|
| Asset Turnover | 0.54 | 0.87 |
| Inventory Turnover | 5.40 | 11.67 |
| Revenue Per Employee | $557.38K | $228.48K |
| Profits Per Employee | $52.89K | -$8.65K |
| Employee Count | 713 | 913 |
Dividends and yields
| Measure | BillionToOne | Industry median |
|---|---|---|
| Earnings Yield | 0.79% | -1.25% |
| FCF Yield | 0.70% | 1.74% |
Shares
| Measure | BillionToOne | Industry median |
|---|---|---|
| Shares Outstanding | 47,187,000 | 58,282,400 |
| Shares Change (YoY) | 296.9% | 2.68% |
| Float | 21,031,600 | 33,780,100 |
| Shares Held by Insiders | 55.4% | 16.4% |
| Shares Held by Institutions | 32.4% | 85.9% |
Taxes
| Measure | BillionToOne | Industry median |
|---|---|---|
| Income Tax | $194.00K | $697.00K |
| Effective Tax Rate | 0.51% | 23.1% |
Scores
| Measure | BillionToOne | Industry median |
|---|---|---|
| Altman Z-Score | 16.07 | 1.96 |
| Piotroski F-Score | 8 | 5 |
| Beneish M-Score | -2.03 | -2.71 |
Calculated by StockData from BillionToOne's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.